How to Better Evaluate, Identify and Manage Shock Patients

April 12, 2016

Recently, Abiomed’s platform of Impella® heart pumps received FDA approval for the treatment of patients experiencing cardiogenic shock so we asked Dr. John Lasala to describe his experiences with Impella while treating shock patients. (Tweet This)


To learn more about the Impella® platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: www.protectedpci.com/indications-use-safety-information/

Subscribe to the Digital Community

Receive weekly updates including case review videos, tips and tricks, specialists opinions, and resources and downloads regarding Protected PCI and Cardiogenic Shock.

Subscribe to the Digital Community

Receive weekly updates including case review videos, tips and tricks, specialists opinions, and resources and downloads regarding Protected PCI and Cardiogenic Shock.